Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$210.97K

Rothblatt Martine A Chairperson & CEO

Transaction date Jul 8, 2026
Public filing date Jul 9, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$554.34 Jul 8, 2026
First close after public filing
$547.06 Jul 10, 2026
30-day return after filing
-3.18% Through Aug 10, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
379 shares @ $556.64
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001106578-26-000094
Filing cohort

Transactions in this filing

Showing 14 of 14
Trades
14
Issuers
1
Estimated value
$6.54M
Buys / sales
0 / 12
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Exercise Jul 8, 2026 $1.29M
United Therapeutics Corp UTHR Sale Jul 8, 2026 $349.47K
United Therapeutics Corp UTHR Sale Jul 8, 2026 $507.21K
United Therapeutics Corp UTHR Sale Jul 8, 2026 $432.1K
United Therapeutics Corp UTHR Sale Jul 8, 2026 $510.19K
United Therapeutics Corp UTHR Sale Jul 8, 2026 $823.24K
United Therapeutics Corp UTHR Sale Jul 8, 2026 $946.35K
United Therapeutics Corp UTHR Sale Jul 8, 2026 $619.88K
United Therapeutics Corp UTHR Sale Jul 8, 2026 $161.72K
United Therapeutics Corp UTHR Current Sale Jul 8, 2026 $210.97K
United Therapeutics Corp UTHR Sale Jul 8, 2026 $391.59K
United Therapeutics Corp UTHR Sale Jul 8, 2026 $122.93K
United Therapeutics Corp UTHR Sale Jul 8, 2026 $179.45K
United Therapeutics Corp UTHR Exercise Jul 8, 2026 $0